Cloning, expression and characterization of Brugia malayi abundant larval protein transcript-2 (BmALT-2) expressed in Pichia pastoris

References

• World Health Organization. Lymphatic filariasis fact sheet [Internet]. Geneva: World Health Organization; c2016 [cited 2016 Nov 16]. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/
   Google Scholar
• Jayakody RL, De Silva CSS, Weerasinghe WMT. Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reaction. Trop Biomed. 1993;10:19–24.
   Google Scholar
• Dreyer G, Addiss D, Noroes J, et al. Direct assessment of the adulticidal efficacy of repeat high-dose invermectin in bancrofitian filariasis. Trop Med Int Health. 1996;1:427–432.
   PubMed Web of Science ®Google Scholar
• Noroes J, Dreyer G, Santos A, et al. Assessment of efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans Roy Soc Trop Med. 1997;91:78–81.
   PubMed Web of Science ®Google Scholar
• Molyneux DH, Taylor MJ. Current status and future prospects of the Global Lymphatic Filariasis Programme. Curr Opin Infect Dis. 2001;14(2):155–159.
   PubMed Web of Science ®Google Scholar
• Gyapong JO, Kumaraswami V, Biswas G, et al. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother. 2005;6(2):179–200.
   PubMed Web of Science ®Google Scholar
• Emilio P. Filariasis: diagnosis, treatment and prevention. Acta Biomed. 2008;79:106–109.
   PubMedGoogle Scholar
• Selkirk ME, Maizels RM, Yazdanbakhsh M. Immunity and the prospects for vaccination against filariasis. Immunobiol. 1992;184(2–3):263–281.
   PubMed Web of Science ®Google Scholar
• Grieve RB, Wisnewski N, Frank GR, et al. Vaccine research and development for the prevention of filarial nematode infections. Pharm Biotechnol. 1995;6:737–768.
   PubMedGoogle Scholar
• Price VL, Kieny MP. Vaccines for parasitic diseases. Current Drug Targets Infect Disord. 2001;1(3):315–324.
   PubMedGoogle Scholar
• Vercruysse J, Schetters TPM, Knox DP, et al. Control of parasitic disease using vaccines: an answer to drug resistance? Rev Sci Tech Off Int Epiz. 2007;26:105–115.
   PubMed Web of Science ®Google Scholar
• Gomez-Escobar N, Bennett C, Prieto-Lafuente L, et al. Heterologous expression of the filarial nematode Bmalt gene products reveals their potential to inhibit immune function. BMC Biol. [Internet]. 2005 [cited 2016 Jun 22];3:8. Available from: http://bmcbiol.biomedcentral.com/articles/10.1186/1741-7007-3-8
   PubMed Web of Science ®Google Scholar
• Ben-Wen , Wang Z, Rush AC, et al. Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode Brugia malayi. BMC Genomics. [Internet]. 2012 [cited 2016 Jun 22];13:184. Available from: http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-13-184
   PubMed Web of Science ®Google Scholar
• Madhumathi J. Development of synthetic and recombinant multi-epitope peptide vaccines for human lymphatic filariasis [dissertation]. Chennai: Anna University; 2010. p. 163–165.
   Google Scholar
• Gregory WF, Atmadja AK, Allen JE, et al. The Abundant Larval Transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun. 2000;68:4174–4179.
   PubMed Web of Science ®Google Scholar
• Murray J, Gregory WF, Gomez-Escobar N, et al. Expression and immune recognition of Brugia malayi VAL-1, a homologue of vespid venom allergens and Ancylostoma secreted proteins. Mol Biochem Parasitol. 2001;118(1):89–96.
   PubMed Web of Science ®Google Scholar
• Anand SB, Kodumudi KN, Reddy MV, et al. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. J Helminthol. 2011;4:1–11.
   Google Scholar
• Anand SB, Murugan V, Prabhu PR, et al. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (BmALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Tropica. 2008;107:106–112.
   PubMed Web of Science ®Google Scholar
• Gnanasekar M, Rao KV, He YX, et al. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun. 2004;72:4707–4715.
   PubMed Web of Science ®Google Scholar
• Madhumathi J, Prince PR, Rao DN, et al. Dominant T-cell epitopes of filarial BmALT-2 and their cytokine profile in BALB/c mice. Parasite Immunol. 2010;32(11–12):760–763.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Mishra PK, Reddy MVR, et al. The larval specific lymphatic filarial BMALT-2: induction of protection using protein or DNA vaccination. Microbiol Immunol. 2004;48:945–955.
   PubMed Web of Science ®Google Scholar
• Thirugnanam S, Pandiaraja P, Ramaswamy K, et al. Brugia malayi: comparison of protective immune responses induced by Bmalt-2 DNA, recombinant BmALT-2 protein and prime-boost vaccine regimens in a jird model. Exp Parasitol. 2007;116(4):483–491.
   PubMed Web of Science ®Google Scholar
• Ganapathy M, Perumal A, Mohan C, et al. Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco. Plant Cell Rep. 2014;33(1):179–188.
   PubMed Web of Science ®Google Scholar
• Buckholz FG, Gleeson MAG. Yeast systems for the commercial production of heterologous proteins. BioTechnol. 1991;9(11):1067–1072.
   PubMed Web of Science ®Google Scholar
• Cregg JM, Cereghino JL, Shi J, et al. Recombinant protein expression in Pichia pastoris. Mol Biotechnol. 2000;16(1):23–52.
   PubMed Web of Science ®Google Scholar
• Cereghino L, Sunga GP, Line AJ, et al. Expression of foreign genes in the yeast Pichia pastoris. Genet Engg. 2001;23:157–169.
   Google Scholar
• Hamilton SR, Davidson RC, Sethuraman N, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Sci. 2006;313(5792):1441–1443.
   PubMed Web of Science ®Google Scholar
• Thill GP, Davis GR, Stillman Cet at., Positive and negative effects of multicopy integrated expression vectors on protein expression in Pichia pastoris. In: Heslot H, Davies J, Florent Jet at., Proceedings of the 6th International Symposium on Genetics of Microorganisms, 2. Paris: Societe Francaise de Microbiologie; 1990. p. 477–490.
   Google Scholar
• Vassileva A, Chugh DA, Swaminathan S, et al. Effect of copy number on the expression levels of Hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Protein Expr Purific. 2001;21(1):71–81.
   PubMed Web of Science ®Google Scholar
• Shen Q, Wu M, Wang HB, et al. The effect of gene copy number and co-expression of chaperone on production of albumin fusion proteins in Pichia pastoris. Appl Microbiol Biotechnol. 2012;96(3):763–772.
   PubMed Web of Science ®Google Scholar
• Canales M, Enríquez A, Ramos E, et al. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle tick. Vaccine. 1997;15(4):414–422.
   PubMed Web of Science ®Google Scholar
• Vu T, Thu H, Dinh T, et al. Cloning, high-level expression, purification, and properties of a novel endo-β;-1, 4-mannanase from Bacillus subtilis G1 in Pichia pastoris. J Microbiol Biotechnol. 2012;22(3):331–338.
   PubMed Web of Science ®Google Scholar
• Cregg JM, Tschopp JF, Stillman C, et al. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Biotechnol. 1987;5:479–485.
   Web of Science ®Google Scholar
• Bo H, Minjian L, Guoqiang H, et al. Expression of Hepatitis B Virus S gene in Pichia pastoris and application of the product for detection of anti-HBs antibody. J Biochem Mol Biolog. 2005;38(6):683–689.
   PubMedGoogle Scholar
• EasySelectô Pichia expression kit: a manual of methods for expression of recombinant proteins using pPICZ and pPICZα in Pichia pastoris. Catalog no. K1740-01. Carlsbad (CA): Invitrogen Corporation.
   Google Scholar
• Lin-Cereghino J, Hashimoto M, Moy A, et al. Direct selection of Pichia pastoris expression strains using new G418 resistance vectors. Yeast. 2008;25(4):2934–299.
   Google Scholar
• Ingham DJ, Beer S, Money S, et al. Quantitative real-time PCR assay for determining transgene copy number in transformed plants. BioTechniques. 2001;31:132–140.
   PubMed Web of Science ®Google Scholar
• Crowe J, Masone BS, Ribbe J. One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin. Mol Biotechnol. 1995;4(3):247–258.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254.
   PubMed Web of Science ®Google Scholar
• Pasamontes L, Denise E, Kurt B. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus. J Gen Viro. 1986;67:2415–2422.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nat. 1970;227(5259):680–685.
   Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnol. 1992;24:145–149.
   PubMedGoogle Scholar
• Fairbanks G, Steck TL, Wallach DFH. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochem. 1971;10:2606–2617.
   PubMed Web of Science ®Google Scholar
• Steentoft C, Vakhrushev SY, Joshi HJ, et al. Precision mapping of the human O-GalNAc glycoproteome through simple cell technology. EMBO J. 2013;32(10):1478–1488.
   PubMed Web of Science ®Google Scholar
• Tschopp JF, Sverlow G, Kosson R, et al. High level secretion of glycosylated invertase in the methylotrophic yeast Pichia pastoris. BioTechnol. 1987;5:1305–1308.
   Web of Science ®Google Scholar
• Patrick MS, Fazenda ML, McNeil B, et al. Heterologous protein production using the Pichia pastoris expression system. Yeast. 2005;22:249–270.
   PubMed Web of Science ®Google Scholar
• Mahalakshmi N, Aparnaa R, Kaliraj P. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model. Scandinavian J Immunol. 2014;80(4):261–270.
   PubMed Web of Science ®Google Scholar
• Anugraha G, Madhumathi J, Prince PR, et al. Chimeric epitope vaccine from multistage antigens for lymphatic filariasis. Scandinavian J Immunol. 2015;82:380–389.
   PubMed Web of Science ®Google Scholar
• Aparnaa R, Kaliraj P. Immunomodulation of ALT-2 and TLR may collude in antigen specific T cell hyporesponsiveness: proposed mechanism for elevated IL-10 levels in Balb/C mice. Acta Parasitol. 2014;59(1):25–30.
   PubMed Web of Science ®Google Scholar
• Madhumathi J, Prince PR, Rao DNet al., Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis. J Helminthol. 2016;19:1–12.
   Web of Science ®Google Scholar